The Freedom of Information Act has allowed the public to free copious amounts of health data from the U.S. government in addition to solving countless transparency issues. At CareSet, which releases DocGraph Datasets, we are especially focused on using FOIA to increase healthcare transparency. The DocGraph Journal was founded on... read more →
Six months ago I was facing a quarter-life crisis. I was working for a company who was serving high net worth individuals. Every weeknight felt like Sunday night, “Ugh. I have to go to work in the morning.” Every morning I’d get to work and of course, I enjoyed working... read more →
HHS finally used the "s"-word (silos) talking about themselves. The Context: When anyone seeks to understand what is happening within HHS, a “search” must be conducted. In the era of paper records, this was a literal, physical search. An HHS employee would go to filing cabinets somewhere and find resources.... read more →
As of July 10, the NPPES data file now contains substantially more data. NPPES is a core data file for us at CareSet. NPPES stands for National Plan and Provider Enumeration System and is the dataset that helps us uniquely identify healthcare providers, using "National Provider Identifiers" or NPI numbers. This... read more →
WASHINGTON, DC (PRWEB) Today CareSet Labs released the DocGraph Hop Teaming Dataset at Datapalooza. This dataset is the most comprehensive open map of the healthcare system in the United States. It is also the largest graph dataset available as open data that uses real names. This release represents the transition of... read more →
CareSet made a big splash at SXSW 2018, hosting Put Down the Scalpel: Non-Invasive Heart Solutions on March 10th at the Austin Convention Center. The session had an all-star cast of subject matter experts, including panelists Patrick Wayte, Senior Vice President, Center for Health Technology and Innovations for The American Heart Association, Cat Oyler,... read more →
How biosimilars are grabbing market share among HCPs. It’s a widely held belief that biosimilars, or “generic” versions of biologics (medicines produced from living organisms), hold great promise to reduce healthcare costs worldwide. Because biosimilars require less money to develop, they typically sell at a discount to... read more →
March of 2011 marked an important day in the history of how we treat cancer. The reason for its importance? In March 2011, the FDA approved a little molecule called Ipilimumab, better known as Yervoy, for use as a first line therapy in metastatic melanoma patients. Now, the FDA approves... read more →
CareSet Labs will be releasing Root NPI Graph, a new version of the “shared Medicare patients in time” provider teaming dataset on June 25 at the 2017 Academy Health ARM Meeting. Conference attendees will be able to get free copies... read more →
CareSet hosted “Cancer Data: Driving Medication Purchase Decisions” at SXSW Interactive on March 12, 2017 at the Austin Convention Center. The session... read more →